Followers | 2 |
Posts | 34 |
Boards Moderated | 0 |
Alias Born | 06/06/2017 |
Monday, June 19, 2017 10:15:59 AM
https://www.twst.com/interview/clinical-advancements-and-drug-launches-in-therapeutics-fuel-investor-enthusiasm
"...the company’s name is Clovis (CLVS), and the market cap there is about $1.4 billion. Going back to the theme that we talked about of targeted therapies, this company is developing a cancer product for patients with specific a mutation in lung cancer called EGFR mutation, and that stands for epidermal growth factor receptor; it’s a type of receptor on the cancer cell that helps stimulate the growth of cells. And in particular, patients within this EGFR mutated class have developed a resistance pattern to the current standard of care, and then they tend to deteriorate rather rapidly.
This company is developing a targeted therapy for a specific mutation there, and the data remains early. This company actually is only in the midst of their — in early Phase II, but from the data that we’ve seen the drug appears quite active, and we think that given the targeted nature of the product, the large unmet need in lung cancer and the data that they generated today, it’s possible that the FDA could be quite accommodative here and have this drug on the markets within a couple of years.
TWST: So real fast track on it?
Recent CLVSQ News
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 07/18/2023 04:15:24 AM
- Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 07/11/2023 04:09:55 PM
- Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments • Edgar (US Regulatory) • 07/11/2023 04:05:29 PM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 07/11/2023 03:43:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/11/2023 01:37:29 PM
FEATURED Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM